FONAR Corporation Reports Q1 Fiscal 2026 Results with Decreased Net Income

FONAR Corporation reported its financial results for the first quarter of fiscal 2026, ending September 30, 2025, revealing a net income of $2.7 million on revenues of $26.0 million. This marks a decrease from the previous year's net income of $4.0 million on revenues of $25.0 million for the same period. The company's operating income also fell from $4.6 million to $3.2 million, reflecting a 30.5% decline. The increase in total revenues was primarily driven by a rise in management and other fees, which grew by $612,000, alongside a $386,000 increase in product sales and service fees.

In terms of operational metrics, FONAR reported an increase in the number of scans performed at its facilities, rising to 55,106 from 53,054 in the prior year. This growth is attributed to improvements in information technology systems, increased shift coverage, and expanded equipment capacity. However, the company's costs and expenses increased by 12.2% to $22.8 million, outpacing revenue growth and contributing to the decline in operating income. Factors influencing the rise in costs included one-time adjustments from prior periods, expenses related to a proposed take-private transaction, and increased credit loss reserves.

FONAR's strategic developments include ongoing negotiations regarding a non-binding proposal from a group led by its CEO and COO to acquire all outstanding common stock not already owned by them. This potential transaction could result in the company no longer being publicly traded. The Board of Directors has formed a Special Committee to evaluate the proposal, which has not yet resulted in any definitive agreements. Additionally, the company is focused on enhancing its MRI facilities and expanding its market presence, with plans for significant capital expenditures in the current fiscal year.

As of September 30, 2025, FONAR's total assets increased to $218.4 million, up from $216.9 million at the end of the previous fiscal year. The company reported a slight increase in total liabilities to $57.0 million, with a notable rise in accounts payable. The working capital decreased marginally to $127.1 million, reflecting a decrease in current assets. The company continues to face challenges from reduced reimbursement rates and increased competition in the diagnostic imaging market, which may impact future profitability.

Looking ahead, FONAR's management remains cautious about the impact of external factors such as government shutdowns and changes in healthcare legislation on its operations. The company is committed to improving its operational efficiency and maintaining profitability despite these challenges. The outlook for the remainder of fiscal 2026 will depend on the successful execution of its strategic initiatives and the overall market conditions affecting the healthcare sector.